Page last updated: 2024-12-07
cyclic dtpa anhydride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diethylenetriamine pentaacetic acid dianhydride: provides an efficient candidate as an imaging contrast agent for disease diagnosis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 100825 |
| SCHEMBL ID | 124918 |
| MeSH ID | M0118867 |
Synonyms (45)
| Synonym |
|---|
| cdtpaa |
| diethylenetriaminepentaacetic anhydride, dtpa |
| diethylenetriamine pentaacetic acid dianhydride |
| 2-[bis[2-(2,6-dioxomorpholin-4-yl)ethyl]amino]acetic acid |
| 23911-26-4 |
| nsc379317 |
| nsc-379317 |
| diethylenetriaminepentaacetic dianhydride, 98% |
| dtpa dianhydride |
| diethylenetriaminepentaacetic acid dianhydride |
| cyclic dtpa anhydride |
| dtpa-anhydride |
| D2424 |
| diethylenetriaminepentaacetic dianhydride |
| n,n-bis[2-(2,6-dioxomorpholino)ethyl]glycine |
| glycine, n,n-bis(2-(2,6-dioxo-4-morpholinyl)ethyl)- |
| nsc 379317 |
| wnm9rlh5x9 , |
| unii-wnm9rlh5x9 |
| dtpa cyclic anhydride |
| FT-0624902 |
| AKOS015893025 |
| 2-(bis(2-(2,6-dioxomorpholino)ethyl)amino)acetic acid |
| SCHEMBL124918 |
| dtpa anhydride |
| diethylenetriaminepentaaceticdianhydride |
| DTXSID30178625 |
| glycine, n,n-bis[2-(2,6-dioxo-4-morpholinyl)ethyl]- |
| mfcd00010697 |
| J-015273 |
| glycine, n,n-bis(2-(2,6-dioxomorpholino)ethyl)- |
| diethylenetriamine-n,n,n',n'',n''-pentaacetic acid n,n''-dianhydride |
| 2,6-morpholinedione, 4,4'-(((carboxymethyl)imino)diethylene)di- |
| diethylenetriaminepentaacetic bisanhydride |
| diethylenetriamine-n,n,n',n'',n''-pentacetic dianhydride |
| dtpaa |
| 1,5-bis(2,6-dioxomorpholino)-3-azapentane-3-acetic acid |
| n,n-bis(2-(2,6-dioxo-4-morpholinyl)ethyl)glycine |
| dtpa-dianhydride |
| AS-40186 |
| 2-(5-bromothien-2-yl)ethanaminehydrobromide |
| AMY18694 |
| A852509 |
| SY050138 |
| 2-[bis[2-(2,6-dioxomorpholino)ethyl]amino]acetic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.58
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.58) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||